Prosecution Insights
Last updated: May 29, 2026

Examiner: LAFAVE, ELIZABETH ROSE

Tech Center 1700 • Art Units: 1684 1799

This examiner grants 55% of resolved cases

Performance Statistics

55.3%
Allow Rate
-9.7% vs TC avg
83
Total Applications
+56.3%
Interview Lift
1462
Avg Prosecution Days
Based on 38 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
36.3%
§102 Novelty
56.9%
§103 Obviousness
0.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17421573 DNA METHYLATION MEASUREMENT FOR MAMMALS BASED ON CONSERVED LOCI Final Rejection ILLUMINA, INC.
17756336 GENETICALLY-DIRECTED SPARSE AND COMPLETE LABELING OF BRAIN CELLS Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17776404 LIBRARY OF BARCODED EXTRACELLULAR VESICLES Final Rejection The University of Tokyo
17633467 HIGH-THROUGHPUT SCREENING PLATFORM FOR ENGINEERING NEXT-GENERATION GENE THERAPY VECTORS Final Rejection Duke University
18009377 A Method for Assessing Transduction Efficiency and/or Specificity of Vectors at Single Cell Level Non-Final OA AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
17610414 METHODS AND COMPOSITIONS FOR ENHANCED GENOME COVERAGE AND PRESERVATION OF SPATIAL PROXIMAL CONTIGUITY Final Rejection ARIMA GENOMICS, INC.
17843612 NGS LIBRARY PREPARATION USING COVALENTLY CLOSED NUCLEIC ACID MOLECULE ENDS Final Rejection Keygene N.V.
18041902 EUKARYOTIC DNA REPLICATION ORIGINS, AND VECTOR CONTAINING THE SAME Non-Final OA UNIVERSITÉ DE MONTPELLIER
17494155 ANTIBODY ARRAY FOR MEASURING A PANEL OF AMYLOIDS Final Rejection Meso Scale Technologies, LLC.
17923506 COMPOSITIONS AND METHODS FOR MODIFYING POLYMERASE-NUCLEIC ACID COMPLEXES Non-Final OA Pacific Biosciences of California, Inc.
17781650 SPATIAL BARCODING Final Rejection CANCER RESEARCH TECHNOLOGY LIMITED
17435610 PROTEIN RESIDUE MAPPING USING A COMBINATION OF DEEP MUTATIONAL SCANNING AND PHAGE DISPLAY HIGH THROUGHPUT SEQUENCING Non-Final OA Fred Hutchinson Cancer Center
18554942 COMPOSITIONS AND METHODS FOR IN VIVO SCREENING OF THERAPEUTICS Non-Final OA Gordian Biotechnology, Inc.
17284853 Single cell full length RNA sequencing Non-Final OA Koninklijke Nederlandse Akademie van Wetenschappen
17721680 BARCODE-BASED NUCLEIC ACID SEQUENCE ASSEMBLY Final Rejection Twist Bioscience Corporation
17430741 QUANTITATIVE MAPPING OF CHROMATIN ASSOCIATED PROTEINS Final Rejection EPICYPHER, INC.
17814147 DROPLET MICROFLUIDICS-BASED SINGLE CELL SEQUENCING AND APPLICATIONS Non-Final OA QINGDAO MGI TECH CO., LTD.
17786464 METHOD AND KIT FOR WHOLE GENOME AMPLIFICATION AND ANALYSIS OF TARGET MOLECULES IN A BIOLOGICAL SAMPLE Non-Final OA Menarini Silicon Biosystems S.P.A.
17751023 METHODS AND SYSTEMS FOR DETERMINING CELL-CELL INTERACTION Non-Final OA Singleron Biotechnologies Inc.
17436044 INTRAGENIC ASSESSMENT AND METHODS THEREFOR Final Rejection THE SYDNEY CHILDREN'S HOSPITALS NETWORK (RANDWICK AND WESTMEAD) (INCORPORATING THE ROYAL ALEXANDRA
17282728 NORMALIZATION CONTROLS FOR MANAGING LOW SAMPLE INPUTS IN NEXT GENERATION SEQUENCING Non-Final OA ARC BIO, LLC
17430605 METHOD OF DETERMINING THE ORIGIN OF NUCLEIC ACIDS IN A MIXED SAMPLE Non-Final OA NIPD GENETICS PUBLIC COMPANY LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month